**Question:** All are true about Hyperoxic Obstructive Cardiomyopathy, except:

A. Hyperoxic cardiomyopathy develops due to chronic exposure to hyperoxia
B. It is characterized by impaired left ventricular relaxation
C. It is associated with reduced arterial oxygen saturation
D. It is commonly seen in neonates with pulmonary hypertension

**Correct Answer:** C. Reduced arterial oxygen saturation

**Core Concept:** Hyperoxic cardiomyopathy is a condition characterized by myocardial dysfunction resulting from prolonged exposure to increased oxygen levels. It is typically seen in patients with chronic lung disease, such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, or lung fibrosis. Exposure to hyperoxia leads to oxidative stress, mitochondrial dysfunction, and apoptosis in myocardial cells.

**Why the Correct Answer is Right:** Reduced arterial oxygen saturation (option C) is a possible manifestation of hyperoxic cardiomyopathy, as it may occur in patients with respiratory disorders causing hypoventilation and hypoxemia. However, the correct answer is not the primary feature of the condition. Hyperoxic cardiomyopathy is caused by prolonged exposure to increased oxygen levels, not hypoxemia.

**Why Each Wrong Option is Incorrect:**

A. Hyperoxic cardiomyopathy (option A) develops due to exposure to high oxygen levels, not chronic hypoxia. However, chronic hyperoxia does contribute to the development of the condition.

B. Hyperoxic cardiomyopathy is characterized by impaired left ventricular relaxation (option B). While myocardial dysfunction does occur, left ventricular relaxation is not a defining feature of the condition.

D. Hyperoxic cardiomyopathy is commonly seen in neonates with pulmonary hypertension (option D). While it can affect neonates, it is not a primary condition in this population, as they are more likely to have primary pulmonary hypertension or other congenital heart defects.

**Clinical Pearl:** Understanding the pathogenesis of hyperoxic cardiomyopathy is crucial for clinicians treating patients with respiratory disorders. In the presence of hypoxia and hyperoxia, clinicians should monitor patients for signs of myocardial dysfunction and intervene appropriately to maintain optimal oxygenation and ventilation.